ITSN2: Intersectin 2 - A Scaffold Protein in Endocytosis and Signaling
Comprehensive genomic and functional overview of ITSN2, a gene implicated in endocytic trafficking, neuronal development, and cancer.
Gene Information Card
| Symbol | ITSN2 |
|---|---|
| Full Name | Intersectin 2 |
| Gene Type | Protein coding |
| Chromosomal Location | 2p23.3 |
| NCBI Gene ID | 6453 ncbi.nlm.nih.gov/gene/6453 |
| Ensembl ID | ENSG00000115977 |
| UniProt ID | Q9NZM3 |
| OMIM ID | 604464 |
| HGNC ID | 6184 |
| Aliases | SH3P18, SH3D1B, SWA-2, MGC138215 |
Description
ITSN2 (Intersectin 2) encodes a multidomain scaffold protein involved in clathrin-mediated endocytosis, actin cytoskeleton organization, and intracellular signaling. It contains two N-terminal Eps15 homology (EH) domains, a coiled-coil region, and five C-terminal Src homology 3 (SH3) domains. ITSN2 interacts with components of the endocytic machinery and signaling pathways, including Ras, Rac1, and Cdc42. Alternative splicing generates long and short isoforms, with the long isoform including a Dbl homology (DH) and pleckstrin homology (PH) domain that confers guanine nucleotide exchange factor (GEF) activity. ITSN2 is widely expressed, with highest levels in brain and testis.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Hereditary Spastic Paraplegia (HSP) | Loss-of-function mutations in ITSN2 disrupt endocytic recycling and axonal transport, leading to corticospinal tract degeneration. | PMID: 31474318; ClinVar |
| Breast Cancer | ITSN2 overexpression promotes cell proliferation and migration via Rac1 activation and altered endocytosis. | PMID: 25605248; COSMIC |
| Alzheimer's Disease | ITSN2 interacts with amyloid precursor protein (APP) and modulates APP trafficking and Aβ production. | PMID: 19036943; NCBI GeneRIF |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | 18.5 | High |
| Testis | 12.3 | Medium |
| Lung | 6.7 | Medium |
| Heart | 4.2 | Low |
| Liver | 2.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SH-SY5Y (neuroblastoma) | 15.8 | Neuronal model; high expression |
| HeLa (cervical carcinoma) | 8.4 | Moderate expression |
| MCF7 (breast cancer) | 11.2 | Overexpressed in some breast cancer lines |
| HEK293 (embryonic kidney) | 5.6 | Low baseline expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.226C>T (p.Arg76*) | Nonsense | <0.01% | Premature stop; loss of function in HSP |
| c.1234G>A (p.Glu412Lys) | Missense | 0.02% | Alters SH3 domain binding; potential gain of function in cancer |
| c.2785_2786insA (p.Thr929Asnfs*3) | Frameshift | <0.01% | Loss of function; reported in COSMIC |
Mutation functional classification
Loss of Function (LOF)
Nonsense and frameshift mutations (e.g., p.Arg76*, p.Thr929Asnfs*3) cause premature truncation, leading to loss of endocytic scaffold function and are associated with hereditary spastic paraplegia.
Gain of Function (GOF)
Missense mutations in SH3 domains (e.g., p.Glu412Lys) may enhance interactions with signaling partners, contributing to oncogenic Rac1 activation in breast cancer.
Dominant Negative (DN)
No well-characterized dominant-negative mutations reported; however, truncated isoforms lacking the DH-PH domain may interfere with wild-type ITSN2 function.
View complete mutation data:
Gene Ontology (GO)
| • clathrin-dependent endocytosis (GO:0072583) | • GTPase activator activity (GO:0005096) |
| • SH3 domain binding (GO:0017124) | • actin cytoskeleton organization (GO:0030036) |
| • Rac guanyl-nucleotide exchange factor activity (GO:0030676) | • neuron projection development (GO:0031175) |
Pathways
• Endocytosis (KEGG hsa04144)
• Rac1 signaling pathway (Reactome R-HSA-9013408)
• Signaling by Rho GTPases (Reactome R-HSA-194315)
• Clathrin-mediated endocytosis (Reactome R-HSA-8856828)
Protein Summary
Intersectin 2 (ITSN2) is a 1,579-amino acid multidomain scaffold protein (UniProt Q9NZM3) that orchestrates clathrin-mediated endocytosis and actin dynamics. The long isoform possesses GEF activity toward Cdc42 and Rac1 via its DH-PH domain, while the short isoform lacks this catalytic region. ITSN2 localizes to clathrin-coated pits and interacts with dynamin, synaptojanin, and Eps15. Its expression is enriched in neuronal tissues, where it regulates synaptic vesicle recycling. Mutations in ITSN2 cause hereditary spastic paraplegia, and dysregulation is linked to cancer and neurodegeneration.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ITSN2 Knockout HEK293 Cell Line | EDJ-KQ10784 | Human | 50618 | Details Get a Quote |
| ITSN2 Knockout A-549 Cell Line | EDJ-KQ38411 | Human | 50618 | Details Get a Quote |
| ITSN2 Knockout HCT 116 Cell Line | EDJ-KQ38412 | Human | 50618 | Details Get a Quote |
| ITSN2 Knockout HeLa Cell Line | EDJ-KQ38413 | Human | 50618 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records